Literature DB >> 19624018

[Effect of Panax notoginseng saponins on vascular intima hyperplasia and PCNA expression in rat aorta after balloon angioplasty].

Jianling Wang1, Lu Wu, Wei Zhang, Changqing Deng.   

Abstract

OBJECTIVE: To explore the effect and the mechanism of panax notoginseng saponins (PNS) on the vascular intima hyperplasia and expression of proliferating cell nuclear antigen (PCNA) after aortic intima injury induced ballcon in rats.
METHOD: Model of aortic intima denudation in rats was established by 2.0 forgarty. The rats were randomly divided into sham group, model group, PNS group and atorvastatin group. Drugs were administered at the second day after the aortic intima injury for 14 days. The injured thoracic aorta segment were taken to detected the vascular morphological changes and expression of PCNA by histomorphology and immunohistochemic methods. RESULT: The intimal area (IA), intimal thickness (IT), hyperplasia ratio of intimal area (HRIA), the ratio of intimal/mesolamella area and thickness in the model group were significantly higher than those of the sham operation (P<0.01). The above indexes in PNS and atorvastatin group were markedly lower than those in the model group (P<0.05). Compared with the sham group, the expression of PCNA in the model was enhanced remarkably (P<0.01). Compared with the model group, the expression of PCNA in PNS and atorvastatin group was significantly lowered (P<0.01).
CONCLUSION: PNS could inhibit intima hyperplasia by inhibiting proliferation of the vascular smooth muscle cell after vascular intima injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19624018

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  6 in total

1.  Effects of ginsenoside Rg2 on the ultraviolet B-induced DNA damage responses in HaCaT cells.

Authors:  Se Eun Ha; Dae Hyun Shin; Hyung Do Kim; Sun Mi Shim; Hack Soo Kim; Bo Hyeon Kim; Jung Sup Lee; Jong Kun Park
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-05-28       Impact factor: 3.000

2.  Exploring mechanisms of Panax notoginseng saponins in treating coronary heart disease by integrating gene interaction network and functional enrichment analysis.

Authors:  Gui Yu; Jie Wang
Journal:  Chin J Integr Med       Date:  2016-05-16       Impact factor: 1.978

Review 3.  Protective effects of panax notoginseng saponins on cardiovascular diseases: a comprehensive overview of experimental studies.

Authors:  Xiaochen Yang; Xingjiang Xiong; Heran Wang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-24       Impact factor: 2.629

Review 4.  Panax notoginseng Saponins for Treating Coronary Artery Disease: A Functional and Mechanistic Overview.

Authors:  Lian Duan; Xingjiang Xiong; Junyuan Hu; Yongmei Liu; Jun Li; Jie Wang
Journal:  Front Pharmacol       Date:  2017-10-17       Impact factor: 5.810

5.  Sanqi panax notoginseng injection for angina pectoris.

Authors:  Xiaochen Yang; Xingjiang Xiong; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-16       Impact factor: 2.629

6.  Panax notoginseng Saponins Attenuate Phenotype Switching of Vascular Smooth Muscle Cells Induced by Notch3 Silencing.

Authors:  Nan Liu; Dazhi Shan; Ying Li; Hui Chen; Yonghong Gao; Yonghua Huang
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-11       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.